Immunohistochemical characterisation of immunological changes at the tumour site after chemo-immunotherapy with doxorubicin, interleukin-2 and interferon-gamma.Angela J. Lumsden, Bruce N. Gray, Jim Codde et al.|PubMed|1996Cited by 6
Improved efficacy of doxorubicin by simultaneous treatment with interferon-gamma and interleukin-2.Angela J. Lumsden, Peter H. van der Meide, Bruce N. Gray et al.|PubMed|1993Cited by 5
Prevention of myelosuppression does not improve the therapeutic efficacy of chemo-immunotherapy.Angela J. Lumsden, Peter H. van der Meide, Jim Codde et al.|PubMed|1992Cited by 2